doi: 10.1001/jamapsychiatry.2024.4789 l Clinical observation and some preliminary studies suggest the GLP-1 medication semaglutidebetter known by brand names like Ozempic, Mounjaro, and Wegovycan reduce cravings and help individuals with alcohol use disorder reduce or stop drinking
when they start and go away, and what you can do to better manage these side effects to get the best from your treatment
Electronic Medicines Compendium (eMC)
Related Reading Ro Wegovy Mochi Wegovy Noom Wegovy Hims Wegovy Pricing and availability current as of July 2026
While semaglutide has demonstrated benefits in improving metabolic markers associated with nonalcoholic fatty liver disease (NAFLD), current evidence does not support its use as protection against alcohol-related liver damage
Novo Nordisk, the manufacturer of Ozempic and Wegovy, explicitly recommends once-weekly dosing and has not studied or endorsed any alternative schedules